CAREMARK RX INC
10-Q, EX-2.3, 2000-08-07
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: CAREMARK RX INC, 10-Q, EX-2.2, 2000-08-07
Next: CAREMARK RX INC, 10-Q, EX-3.3, 2000-08-07



<PAGE>   1
                                                                     EXHIBIT 2.3

                      AMENDMENT NO. 17 TO THE AMENDED AND
                  RESTATED OPERATIONS AND SETTLEMENT AGREEMENT


         This Amendment No. 17 ("Amendment") to the Amended and Restated
Operations and Settlement Agreement, as amended, (the "Agreement") is entered
into as of July 3, 2000, among the Commissioner of the Department of
Corporations of the State of California (the "Commissioner" acting for himself
and the Department of Corporations of the State of California (collectively,
the "State")), J. Mark Abernathy, as Special Monitor-Examiner, Caremark Rx,
Inc., a Delaware corporation, f/k/a MedPartners, Inc., and its successors and
assigns ("MedPartners") and MedPartners Provider Network, Inc., a California
corporation ("MPN"), as a debtor and debtor in possession in the Bankruptcy
Case. Capitalized terms not otherwise defined herein shall have the meanings
ascribed to them in the Agreement.


                                    RECITALS

         WHEREAS, the parties entered into the Agreement as of June 16, 1999;
and

         WHEREAS, the parties have previously entered into Amendments Nos. 1
through 16 to the Agreement.

         NOW THEREFORE, in consideration of the mutual covenant and agreements
contained herein and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties agree as follows:


                                   AGREEMENT

         1.       Section 13.2 of the Agreement is hereby amended by deleting
"July 3, 2000" and inserting in its place "July 31, 2000."

         2.       The Agreement shall remain unchanged in all other respects.

         3.       This Amendment may be executed in one or more counterparts
each of which, when executed and delivered, shall be deemed to be an original,
and all of which, when taken together, shall constitute but one and the same
agreement. Delivery of an executed counterpart of this Amendment by facsimile
shall be equally effective as delivery of an original executed counterpart of
this Amendment.
<PAGE>   2

         IN WITNESS WHEREOF, the parties hereto have executed this Amendment to
be executed as of the date first above written.


                            CAREMARK RX, INC.
                            a Delaware corporation

                            By    /s/ EDWARD L. HARDIN, JR.
                               -----------------------------------------------
                               Name:  Edward L. Hardin, Jr.
                               Title: EVP & General Counsel

                            MEDPARTNERS PROVIDER NETWORK, INC.,
                            a California corporation

                            By    /s/ DON GARNER
                               -----------------------------------------------
                               Name:  Don Garner
                               Title: Corporate Secretary

                            COMMISSIONER OF THE DEPARTMENT OF
                            CORPORATIONS

                            By    /s/ WILLIAM KENEFICK
                               -----------------------------------------------
                               Name:  William Kenefick
                               Title: Acting Commissioner of the Department of
                                      Corporations

                            J. MARK ABERNATHY,
                            as Special Monitor-Examiner and not individually

                            By    /s/ J. MARK ABERNATHY
                               -----------------------------------------------
                               Name:  J. Mark Abernathy
                               Title: J. Mark Abernathy,
                                      as Special Monitor-Examiner



                                       2






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission